Terns Pharmaceuticals, Inc. (TERN) Social Stream
TERNS PHARMACEUTICALS INC (TERN) Price Targets From Analysts
Use the tables below to see what analysts covering TERNS PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-22 | 1 | $19 | $19 | $19 | $5.17 | 267.5% |
| 2022-03-07 | 2 | $19 | $19 | $19 | $5.17 | 267.5% |
| 2022-05-18 | 2 | $6 | $6 | $6 | $5.17 | 16.05% |
| 2022-08-10 | 2 | $5 | $5 | $5 | $5.17 | -3.29% |
| 2022-09-12 | 3 | $6 | $5 | $5.5 | $5.17 | 6.38% |
| 2022-11-11 | 4 | $9 | $5 | $6.666 | $5.17 | 28.94% |
| 2022-11-21 | 4 | $9 | $6 | $7 | $5.17 | 35.4% |
| 2022-12-20 | 4 | $14 | $6 | $8.666 | $5.17 | 67.62% |
| 2022-12-29 | 4 | $14 | $6 | $9 | $5.17 | 74.08% |
| 2023-02-07 | 5 | $19 | $6 | $11.5 | $5.17 | 122.44% |
| 2023-03-29 | 6 | $19 | $9 | $14 | $5.17 | 170.79% |
| 2023-05-19 | 6 | $19 | $10 | $14.2 | $5.17 | 174.66% |
| 2023-05-31 | 7 | $23 | $10 | $15.666 | $5.17 | 203.02% |
| 2023-06-07 | 8 | $23 | $10 | $16 | $5.17 | 209.48% |
| 2023-06-22 | 10 | $23 | $10 | $16 | $5.17 | 209.48% |
| 2023-08-08 | 10 | $23 | $10 | $16.222 | $5.17 | 213.77% |
| 2023-08-09 | 10 | $25 | $8 | $16.333 | $5.17 | 215.92% |
The Trend in the Analyst Price Target
TERN's average price target has moved down $12.67 over the prior 29 months.
TERN reports an average of 37.87% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-28 | 4 | 9 | 5 | 6.666 | 5.60 | 19.04% |
| 2022-11-21 | 4 | 9 | 6 | 7.000 | 5.44 | 28.68% |
| 2022-12-29 | 5 | 14 | 6 | 9.000 | 9.51 | -5.36% |
| 2023-06-07 | 8 | 23 | 10 | 16.000 | 11.87 | 34.79% |
| 2023-08-09 | 10 | 25 | 8 | 16.333 | 6.03 | 170.86% |
TERN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.4 | 8 | 0 | 2 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 48 weeks, TERN's average broker recommendation rating improved by 0.6.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, TERNS PHARMACEUTICALS INC's average analyst price target is greater than 334.91% of them.
- TERNS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1375.9% of all US stocks.
- TERN has a greater number of analysts covering the stock than 1342.77% of stocks in the small market cap category.
- In the context of stocks in the small market cap category, TERNS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1146.07% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TERNS PHARMACEUTICALS INC are ADAG, LGVN, and LVTX.
View All Top Stocks by Price Target
Is TERN a Buy, Hold or Sell? See the POWR Ratings now!